[
  {
    "ts": null,
    "headline": "Some May Be Optimistic About Humana's (NYSE:HUM) Earnings",
    "summary": "NYSE:HUM 1 Year Share Price vs Fair Value Explore Humana's Fair Values from the Community and select yours Humana...",
    "url": "https://finnhub.io/api/news?id=16d893621145f17f9273e76351d537c6824a22847c2e22796191c32d5bd52e24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754481740,
      "headline": "Some May Be Optimistic About Humana's (NYSE:HUM) Earnings",
      "id": 136237496,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "NYSE:HUM 1 Year Share Price vs Fair Value Explore Humana's Fair Values from the Community and select yours Humana...",
      "url": "https://finnhub.io/api/news?id=16d893621145f17f9273e76351d537c6824a22847c2e22796191c32d5bd52e24"
    }
  },
  {
    "ts": null,
    "headline": "The great Medicare Advantage contraction appears set to continue",
    "summary": "Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS showed the success of the strategy.",
    "url": "https://finnhub.io/api/news?id=daf3e8990696ba938d72e19189c5e06ac3e761c57685de1001ac7e2b690ab243",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754476977,
      "headline": "The great Medicare Advantage contraction appears set to continue",
      "id": 136239038,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS showed the success of the strategy.",
      "url": "https://finnhub.io/api/news?id=daf3e8990696ba938d72e19189c5e06ac3e761c57685de1001ac7e2b690ab243"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.",
    "summary": "Healthcare stocks have been the sick man of the  this year.  The  exchange-traded fund has fallen 3.7% this year, far worse than the S&P 500’s 7.1% rise.  The ETF includes everything from insurers to pharma companies to medical-device makers, and that diversity usually helps the group weather the tough times.",
    "url": "https://finnhub.io/api/news?id=9a8e4064a99bde35e95e225106c6771e3156aa6b8dc50846fccc1e9bb0a4e06f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754469000,
      "headline": "Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.",
      "id": 136232196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Healthcare stocks have been the sick man of the  this year.  The  exchange-traded fund has fallen 3.7% this year, far worse than the S&P 500’s 7.1% rise.  The ETF includes everything from insurers to pharma companies to medical-device makers, and that diversity usually helps the group weather the tough times.",
      "url": "https://finnhub.io/api/news?id=9a8e4064a99bde35e95e225106c6771e3156aa6b8dc50846fccc1e9bb0a4e06f"
    }
  }
]